XLH Matters 2022: Insights and recommendations to improve outcomes for people living with X-linked hypophosphataemia (XLH)

• Lothar Seefried,
• Ali Alzahrani,
• Pedro Arango Sancho,
• Justine Bacchetta,
• Rachel Crowley,
• Francesco Emma,
• Jonathan Gibbins,
• Anna Grandone,
• Muhammad Kassim Javaid,
• Gabriel Mindler,
• Adalbert Raimann,
• Anya Rothenbuhler,
• Ian Tucker,
• Leonid Zeitlin,
• Agnès Linglart

Affiliations

Lothar Seefried

Orthopedic Institute, König-Ludwig Haus, University of Würzburg

Ali Alzahrani

King Faisal Specialist Hospital and Research Center

Pedro Arango Sancho

Department of Pediatric Nephrology, Hospital Sant Joan de Déu

Justine Bacchetta

Pediatric Nephrology, Reference Center for Rare Diseases of Calcium and Phosphate, Filières OSCAR et ORKID, INSERM1033, Hospices Civils de Lyon

Rachel Crowley

St Vincent’s University Hospital and Rare Disease Clinical Trial Network, University College Dublin

Francesco Emma

Division of Nephrology, Children’s Hospital Bambino Gesù–IRCCS

Jonathan Gibbins

Evelina London Children’s Hospital

Anna Grandone

Department of Woman, Child, General and Specialized Surgery, University of Campania L. Vanvitelli

Muhammad Kassim Javaid

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford

Gabriel Mindler

Department of Pediatric Orthopaedics, Orthopaedic Hospital Speising

Adalbert Raimann

Vienna Bone and Growth Center

Anya Rothenbuhler

APHP, Endocrinology and Diabetology for Children, Bicêtre Paris Saclay Hospital

Ian Tucker

Bristol Royal Hospital for Children, University Hospitals Bristol and Weston NHS Foundation Trust

Leonid Zeitlin

Pediatric Bone Clinic, Orthopedic Department, Dana-Dwek Children’s Hospital, Tel-Aviv Medical Center

Agnès Linglart

APHP, Endocrinology and Diabetology for Children, Bicêtre Paris Saclay Hospital